Skip to main content

Extranodal Natural Killer/T-cell Lymphoma in Malawi

September 6, 2017

September 2017- Our experience with these patients highlights that ENKTCL does indeed occur in SSA, increases familiarity with ENKTCL among clinicians and pathologists throughout the region, and emphasizes the need for better diagnosis and treatment for this neglected population.

Salvage Chemotherapy for Adults with Relapsed or Refractory Lymphoma

August 20, 2017

August 2017 – Lymphoma is highly associated with HIV in sub-Saharan Africa and contributes to worse outcomes relative to resource-rich settings. This study describes 21 patients with relapse or refractory lymphoma who were prospectively treated with salvage chemotherapy in Malawi.

HIV-associated malignancies in sub-Saharan Africa: an overview

January 1, 2017

January, 2017 – This review highlights recent developments for HIV-associated malignancies in low and middle income countries and suggests that sustained investment within these settings can help catalyze a cancer care and research agenda that benefit patients worldwide.

CHOP Chemotherapy for Non-Hodgkin Lymphoma with and without HIV

March 15, 2016

March 2016 – With no previous prospective studies of aggressive non-Hodgkin lymphoma treated with CHOP in sub-Saharan Africa, results of this study suggest that CHOP can be safe, effective, and feasible for treating aggressive NHL among HIV+/- individuals in Malawi.